Author

G. Ahlenstiel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:flow cytometry· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Abayasingam· 1 shared A. Adhikari· 1 shared A. J. Morgan· 1 shared A. J. Potter· 1 shared A. Maczurek· 1 shared A. R. Lloyd· 1 shared A. Terry· 1 shared A. W. Bartlett· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Abayasingam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintDec 21, 2021

Longitudinal characterisation of phagocytic and neutralisation functions of anti-Spike antibodies in plasma of patients after SARS-CoV-2 infection.

A. Adhikari, A. Abayasingam, C. Rodrigo…·N. Tedla

This study shows that phagocytic and neutralisation functions of anti-Spike antibodies persist in SARS-CoV-2 convalescents despite declining antibody titers, with improved antibody affinity correlating with maintained effector functions.

DOI 10.1101/2021.12.21.473774

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivApr 6, 2019

The Role of CD147 in Leukocyte Aggregation in Liver Injury

N. Main, C. Yee, A. Terry…·N. A. Shackel

This study identifies CD147 as a mediator of leukocyte aggregation in liver injury, showing that blocking CD147 reduces aggregate formation and liver damage without affecting overall leukocyte numbers.

DOI 10.1371/journal.pone.0215557

humanmouse

𝕏 PostBluesky